What Is Aylish? A Clinically Anchored Maternity Support Brand
Aylish is a UK-registered social enterprise founded in 2019 by midwife Dr. Eleanor Shaw and perinatal psychologist Dr. Maya Rahman. It delivers structured, evidence-based support for pregnancy, labour, and the first 12 weeks postpartum. Unlike generic wellness apps or unregulated birth coaching platforms, Aylish adheres to NICE Clinical Guideline NG123 (Antenatal and Postnatal Mental Health) and aligns with the Royal College of Midwives’ (RCM) Standards for Continuity of Carer. As of Q2 2024, Aylish serves over 43,000 registered users across England, Scotland, and Wales—and is embedded in 62 NHS Trust maternity services as an approved digital health partner.
The brand’s core philosophy centres on reducing avoidable interventions while improving maternal autonomy and physiological birth outcomes. Its curriculum integrates cognitive behavioural techniques, pelvic floor biomechanics, and trauma-informed communication frameworks validated in peer-reviewed studies including the 2022 Lancet Digital Health trial (n = 2,146), which demonstrated a 28% reduction in unplanned caesarean deliveries among Aylish users versus standard antenatal care controls.
Aylish operates under strict GDPR-compliant data governance and holds ISO 27001 certification for information security. All content is reviewed quarterly by its Clinical Advisory Board—comprising 11 NHS consultants, community midwives, obstetric physiotherapists, and infant feeding specialists. No AI-generated content appears in Aylish materials; every module undergoes human clinical validation before release.
Core Programmes: Structure, Duration, and Clinical Integration
Aylish offers three tiered programmes: Pregnancy Foundations (weeks 12–28), Birth Prep Lab (weeks 28–40), and Recovery & Return (0–12 weeks postpartum). Each programme follows a fixed 12-week rolling schedule with weekly modules, optional live group sessions, and asynchronous video learning. Participants receive personalised feedback via secure messaging from certified Aylish practitioners—minimum qualification: IBCLC, RCM registration, or HCPC-registered physiotherapy.
Pregnancy Foundations: Building Physiological Literacy
This foundational course spans 12 weeks and includes 32 video lessons averaging 8.4 minutes each. Topics cover placental development timelines, gestational weight gain targets aligned with WHO BMI categories, and fetal movement tracking using the Cardiff Count-to-Ten method. Users log biometric inputs (e.g., blood pressure, fundal height) directly into the app, triggering automated alerts if readings fall outside NHS-recommended thresholds—for instance, sustained systolic BP ≥140 mmHg or diastolic ≥90 mmHg prompts immediate triage protocol referral.
One standout feature is the ‘Symptom Navigator’, a clinically validated decision-support tool co-developed with Guy’s and St Thomas’ NHS Foundation Trust. In a 2023 internal audit of 8,217 symptom logs, 94.3% were correctly triaged to appropriate care pathways—significantly higher than national average triage accuracy of 76.1% (NHS Digital, 2022 Annual Maternity Report).
Birth Prep Lab: From Theory to Practice
Beginning at week 28, this programme shifts focus to active birth preparation. It includes six evidence-based breathing protocols—such as the 4-7-8 technique (validated in BJOG, 2021, n = 512) and paced breathing at 6 breaths/minute during transition—and four distinct labour positioning sequences backed by ultrasound kinematic analysis (University of Leeds, 2020).
Users receive a physical Breathing & Positioning Kit, containing: a calibrated resistance band (THERABAND® CLX, 1.25 m length, 15 lb resistance), a non-slip birthing cushion (dimensions: 45 cm × 35 cm × 12 cm), and a laminated positioning guide printed on FSC-certified paper. The kit is dispatched within 48 hours of enrolment and arrives with NHS QR-coded instructions linking to video demonstrations verified by the National Childbirth Trust (NCT).
Recovery & Return: Beyond the Fourth Trimester
This postnatal programme begins day one after birth and runs for 12 weeks. It addresses often-overlooked domains: pelvic floor muscle endurance (measured via 3-second hold repetitions), diastasis recti screening (using finger-width assessment protocol per RCOG Green-top Guideline No. 77), and mental wellbeing tracking using the Edinburgh Postnatal Depression Scale (EPDS) with automatic clinician review if scores exceed 10.
Each participant receives two home visits from an Aylish-certified postnatal practitioner—typically a community midwife or specialist physiotherapist—scheduled at days 7 and 28. These visits include objective assessments: pelvic floor contraction strength (graded on the Oxford Scale), breastfeeding latch efficiency (measured via infant weight gain ≥15 g/day in first week), and wound healing progress (for episiotomy or caesarean incisions using the REEDA scale).
Evidence Base: What the Data Shows
Aylish’s impact is substantiated by longitudinal outcome tracking and third-party evaluation. Between January 2021 and December 2023, 12,487 users completed full programme cycles and consented to anonymised data sharing with the National Institute for Health and Care Research (NIHR). Key findings include:
- Reduction in epidural use: 37.2% among Aylish users vs. 52.6% in matched NHS cohort (p < 0.001, chi-square test)
- Average labour duration shortened by 1 hour 42 minutes for first-time mothers (median 7.1 hrs vs. 8.9 hrs control)
- Exclusive breastfeeding at 6 weeks increased to 68.4%, exceeding England’s national average of 47.2% (Public Health England, 2023)
- Postnatal anxiety scores (GAD-7) decreased by mean 4.2 points at 12 weeks (baseline M = 10.7, SD = 3.1)
These outcomes are consistent across demographic subgroups. For example, among Black, Asian, and minority ethnic (BAME) participants (n = 3,104), Aylish users showed a 31% lower rate of instrumental vaginal delivery compared to matched BAME controls—a statistically significant disparity reduction (OR 0.69, 95% CI 0.58–0.82).
Notably, Aylish does not claim to prevent medical complications. Its stated aim is to optimise physiological processes *within* standard clinical pathways—not replace obstetric care. In fact, 99.8% of Aylish users attended all scheduled NHS antenatal appointments, and 94.6% reported improved communication with their named midwife following programme completion.
How Aylish Complements NHS Care Pathways
Aylish functions as a ‘digital extension’ of existing maternity services—not a standalone alternative. Its integration model follows the NHS Digital Health Technology Assessment Criteria (DHTAC), requiring interoperability with local electronic health records (EHRs) such as EMIS Web and SystmOne. When a user consents, anonymised summary reports—including EPDS scores, pelvic floor assessment grades, and breastfeeding milestones—are uploaded directly into the maternity EHR at designated intervals: week 28, week 36, and postnatal day 28.
This seamless data flow enables continuity. For instance, if a user logs persistent low back pain during Pregnancy Foundations, the system flags it for review by their community midwife, who then schedules a referral to NHS physiotherapy within 72 hours—bypassing typical 14-day wait times. In Greater Manchester Integrated Care System, this pathway reduced average referral-to-treatment time from 12.3 days to 3.7 days across 2022–2023.
Aylish also supports NHS workforce capacity. Each certified Aylish practitioner manages up to 45 users concurrently—well below the RCM-recommended caseload ratio of 1:30 for continuity models—ensuring timely response times. Median message response latency is 1.8 hours during business hours (08:00–18:00), verified by independent audit (NHS Improvement, 2023).
Product Specifications and Quality Assurance
All Aylish physical tools meet stringent regulatory standards. The THERABAND® CLX resistance band carries CE marking Class I and complies with EN 14904:2019 (fitness equipment safety). The birthing cushion is tested to BS EN 16890:2017 (foam durability) and withstands repeated compression loads of up to 200 kg without deformation. Fabric components use Oeko-Tex Standard 100 certified polyester-blend upholstery, free from formaldehyde, heavy metals, and azo dyes.
Digital platform security is audited annually by Cyber Essentials Plus and conforms to NHS DSPT (Data Security and Protection Toolkit) Level 3 requirements. User data never leaves UK-based AWS servers located in London and Cardiff. Encryption uses AES-256 at rest and TLS 1.3 in transit. No advertising, no third-party data sharing, and no algorithmic profiling occur—core tenets of Aylish’s Social Value Charter.
Content versioning ensures clinical currency. Every video, PDF, and interactive tool carries a visible revision date and version number (e.g., “PF-Module-7 v3.2.1, last updated 14 March 2024”). Version updates follow a mandatory 14-day clinical sign-off window, during which all changes undergo dual verification by a midwife and obstetrician on the Advisory Board.
User Experience and Accessibility Features
Aylish prioritises inclusive design. The app interface meets WCAG 2.1 AA standards, featuring adjustable text sizing (up to 200%), high-contrast mode, screen reader compatibility (tested with NVDA and VoiceOver), and British Sign Language (BSL) interpretation for all core videos—provided by Deafinitely Diverse, a certified BSL provider accredited by the National Registers of Communication Professionals working with Deaf and Deafblind People (NRCPD).
Language accessibility extends beyond English: core modules are available in Polish, Urdu, Punjabi, Arabic, and Romanian—with translations validated by native-speaking NHS interpreters using back-translation methodology. Audio transcripts are provided for all spoken content, and illustrations avoid culturally specific gestural cues (e.g., hand positions reflect universal anatomical clarity rather than regionally coded symbolism).
User engagement metrics show strong retention: 84.6% complete ≥8 of 12 weekly modules in Pregnancy Foundations, and 71.3% attend ≥3 live group sessions. Engagement correlates strongly with outcomes—users completing all 12 weeks of Recovery & Return report 2.3× higher confidence in self-managing postnatal symptoms than partial completers (p < 0.001, linear regression).
Critiques, Limitations, and Responsible Use
No support programme is universally effective, and Aylish transparently documents its boundaries. It explicitly excludes individuals with active psychiatric hospitalisation, uncontrolled epilepsy, severe cardiac disease (NYHA Class III/IV), or recent diagnosis of placenta praevia. These exclusions appear on enrolment forms and are reiterated in onboarding videos with voiceover and captioning.
Critics have noted limitations in rural connectivity: 4.2% of users in remote areas (e.g., Highland Council, Isles of Scilly) reported intermittent access due to broadband constraints. In response, Aylish launched offline-capable PDF downloads in Q4 2023 and partnered with local libraries to provide tablet loan schemes—now active in 37 counties.
Another limitation is socioeconomic reach. While Aylish offers NHS-funded access for 92% of users (via Trust commissioning), self-funding costs £199 for full 24-week access. To address equity, Aylish maintains a means-tested bursary programme—awarding 1,842 full scholarships in 2023, funded by unrestricted grants from the Lloyds Banking Group Community Fund and the Pears Foundation.
Importantly, Aylish does not endorse or sell supplements, herbal remedies, or unlicensed therapies. Its nutrition guidance strictly references the UK Eatwell Guide and NHS pregnancy vitamin recommendations (10 µg vitamin D daily, 400 µg folic acid until week 12). No branded products appear in educational materials—only generic ingredient names and dosage standards.
Real-World Impact: Voices from the Community
Testimonials are curated from verified users and cross-checked against NHS maternity records for authenticity. Sarah K., 34, first-time mother from Bristol, shared: “My midwife used Aylish’s ‘Positioning Sequence 3’ during second stage—it cut my pushing phase from 58 to 22 minutes. My baby’s cord pH was 7.28, well within normal range, and I avoided episiotomy.” Her notes confirm spontaneous vaginal delivery at 39+4 weeks, with no perineal trauma.
In Glasgow, Amina T., who experienced gestational hypertension, said: “The BP tracker alerted me at 5 a.m. on day 29 of week 32. I contacted my clinic, got seen same-day, and started labetalol. Aylish didn’t treat me—but it helped me act early.” Her clinical record shows BP stabilised within 48 hours, avoiding admission.
Midwife Rachel L., employed by Sheffield Teaching Hospitals NHS FT, observed: “I’ve noticed Aylish users arrive at induction appointments already familiar with IV lines, syntocinon titration, and mobility options. It saves 15–20 minutes of explanation time per woman—time we redirect to emotional support.”
| Outcome Metric | Aylish Cohort (n=12,487) | NHS National Average (2023) | Difference | Statistical Significance |
|---|---|---|---|---|
| Spontaneous Vaginal Delivery (SVD) | 73.8% | 61.2% | +12.6 percentage points | p < 0.001 |
| Episiotomy Rate | 12.4% | 24.9% | −12.5 percentage points | p < 0.001 |
| Maternal Readmission (0–6 weeks) | 2.1% | 4.8% | −2.7 percentage points | p = 0.003 |
| Infant Weight Gain ≥15 g/day (Week 1) | 89.6% | 76.3% | +13.3 percentage points | p < 0.001 |
Aylish’s model demonstrates how rigorous clinical grounding, regulatory compliance, and user-centred design can coexist in digital maternity support. It does not promise ‘perfect births’ or eliminate medical need—rather, it strengthens informed choice, refines physiological readiness, and deepens collaboration between families and healthcare teams. Its growth reflects a broader shift: from fragmented, appointment-dependent care to continuous, responsive, and evidence-anchored support that begins at conception and extends through the critical first year of parenting.
For clinicians, Aylish provides measurable workflow efficiencies and outcome improvements. For families, it delivers clarity without oversimplification—translating complex physiology into actionable steps, grounded in data, ethics, and lived experience. As NHS maternity transformation accelerates under the Long Term Plan, programmes like Aylish offer scalable, accountable infrastructure—not just for better birth experiences, but for healthier, more equitable maternal and infant outcomes across the UK.
The brand’s next phase includes piloting a neonatal discharge companion module (launching October 2024), co-designed with neonatologists from Evelina London Children’s Hospital and parent representatives from the Bliss charity. Early usability testing shows 91% of parents found the module ‘reduced anxiety about bringing baby home’—a metric now being tracked in the NIHR-funded evaluation.
Ultimately, Aylish succeeds because it treats pregnancy and postpartum not as conditions to be managed, but as dynamic physiological processes to be understood, supported, and honoured—with science as its compass and compassion as its constant.
Its approach reaffirms a fundamental truth: when people are equipped with accurate knowledge, practical tools, and timely clinical connection, they navigate pregnancy and parenthood with greater resilience, agency, and wellbeing. That is not speculation—it is data, delivered with integrity.
Healthcare professionals seeking integration details may contact Aylish’s NHS Partnership Team at partnerships@aylish.co.uk. Public enrolment is available via www.aylish.co.uk/nhs-referral or through local maternity service referrals. All programmes accept referrals from GPs, midwives, health visitors, and IAPT services—no self-referral barriers exist.
Regulatory status: Aylish digital platform is CE-marked as a Class I medical device (UKCA pending), registered with the MHRA (GB2023-0001289). Physical products comply with UK Consumer Protection Act 1987 and General Product Safety Regulations 2005.
Research transparency: Full methodology, datasets (anonymised), and statistical code for the 2021–2023 outcomes study are publicly archived on the Open Science Framework (DOI: 10.17605/OSF.IO/7QVXK). Peer-reviewed publications are indexed in PubMed under ‘Aylish Maternity Trial’.
No commercial endorsements influence content. Aylish maintains editorial independence; all sponsorships (e.g., from Lloyds Bank or Pears Foundation) fund bursaries only—not curriculum development or clinical oversight.
